Streetbeat News

Products Services

AVTX

BDRX

XLO

Avalo Therapeutics (AVTX) saw a 406% increase after acquiring an Anti-IL-1β mAb and announcing a private placement financing of up to $185 million. Xilio Therapeutics (XLO) experienced a 399% surge following an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program and a $11.3 million private placement equity financing. Biodexa (BDRX) shares rose by 46% as its MTX110 showed promise in extending life expectancy against aggressive brain cancers.

Portfolio Pulse from ryanfaloona@benzinga.com

March 28, 2024 | 12:36 pm

NAOV

NanoVibronix, Inc. (NASDAQ:NAOV) has announced a partnership with Veranex, Inc. to develop the next generation of its UroShield and PainShield products. The collaboration aims to enhance therapeutic functionality, increase satisfaction among clinicians and patients, and reduce production costs through Veranex's research and development services.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:36 pm

AMZN

BOTZ

GOOG

GOOGL

META

MSFT

NVDA

SMH

Nvidia Corp dominates the data center GPU market with a 92% share, highlighting U.S. leadership in generative AI. The company's CUDA platform is widely used by developers, contributing to its market value surge to $1.73 trillion by 2024. U.S. tech giants like Meta Platforms, Amazon, Microsoft, and Alphabet lead in cloud infrastructure and AI investments. Nvidia's sales from data centers are expected to constitute over 85% of its total revenue. The stock has surged 242% in the last 12 months, with exposure available through VanEck Semiconductor ETF and Global X Robotics & Artificial Intelligence ETF.

Portfolio Pulse from Anusuya Lahiri

March 28, 2024 | 12:35 pm

PTCT

PTC Therapeutics has submitted a Marketing Authorization Application (MAA) for Sepiapterin, a treatment for PKU, to the European Medicines Agency (EMA). This marks the first marketing authorization submission for Sepiapterin, with plans for additional global submissions in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:34 pm

GILD

The FDA has expanded the indication for Gilead Sciences' Vemlidy to include the treatment of chronic hepatitis B virus (HBV) infection in pediatric patients aged six years and older, weighing at least 25kg. This decision is based on the demonstrated efficacy and safety profile of Vemlidy in this patient group.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:33 pm

LEGH

MIRM

SNOW

Insider purchases at Snowflake, Legacy Housing, Mistras Group, and Mirum Pharmaceuticals signal confidence in these companies. Snowflake's CEO bought shares worth $5M, despite a recent downgrade. Legacy Housing and Mistras Group saw insider buys after reporting disappointing financial results. Mirum Pharmaceuticals' CFO purchased shares following FDA approval of its drug, Livmarli.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 12:33 pm

RSLS

ReShape Lifesciences has received a notice of allowance for an additional US patent related to its intragastric balloon system. This development could enhance the company's intellectual property portfolio and potentially its market position in obesity management solutions.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:31 pm

INZY

MESO

PNTG

SPRY

STIM

As of March 28, 2024, five health care stocks are considered overbought based on their RSI values, indicating potential short-term declines. These include The Pennant Group, Inc. (PNTG), Mesoblast Limited (MESO), ARS Pharmaceuticals, Inc. (SPRY), Neuronetics, Inc. (STIM), and Inozyme Pharma, Inc. (INZY). Each company has recently reported significant developments or financial results, contributing to rapid stock price increases and high RSI values.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 12:30 pm

VZIO

WMT

Walmart Inc (NYSE:WMT) plans to refile its acquisition documents for Vizio Holding Corp (NYSE:VZIO) after withdrawing its initial filing to allow more time for antitrust review. The over $2 billion deal aims to enhance Walmart's advertising revenue and customer services by leveraging Vizio's expertise in TVs, advertising, and streaming. The refiling follows discussions with the Federal Trade Commission and the Department of Justice, with a new waiting period set to expire on April 29, 2024.

Portfolio Pulse from Shivani Kumaresan

March 28, 2024 | 12:28 pm

WKSP

Worksport Ltd. (NASDAQ:WKSP) has received the necessary custom solar panels to begin production of the SOLIS Solar Tonneau Cover in New York. This marks a significant step towards the product's market launch this summer. The solar panels, boasting high power output and flexibility, are crucial for the innovative cover designed for pickup trucks. Worksport is also preparing to introduce the COR Battery System, complementing the solar cover. CEO Steven Rossi highlights this development as a testament to the team's dedication, aiming to impact the automotive and renewable energy sectors positively.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:12 pm